Tetra Bio-Pharma Signs Co-development and Distribution Partnership Term Sheet
OTTAWA, ONTARIO–(Marketwired – March 8, 2018) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in [...]
Professional Services News
Knight has Less Skin in the Game with Medimetriks
MONTREAL, QUEBEC–(Marketwired – March 8, 2018) - Knight Therapeutics Inc. (TSX:GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, announced today that [...]
Oncolytics Biotech(R) Chief Medical Officer to Facilitate Roundtable Discussion at the US Immuno-Oncology Strategy Meeting
CALGARY, AB and SAN DIEGO, CA–(Marketwired – March 08, 2018) – Oncolytics Biotech®, Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, also known as [...]
Novoheart’s Landmark, Peer-Reviewed Study Published, Recognizing the Effectiveness of the World’s First and Only Human Heart-in-a-Jar
VANCOUVER, BRITISH COLUMBIA–(Marketwired – March 8, 2018) - (TSX VENTURE:NVH)(FRANKFURT:3NH) “Human heart-in-a-jar” technology recognized by the scientific community for [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
TUSTIN, Calif., March 07, 2018 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to [...]
Relevium Launches New Aloe Vera Based Products
MONTREAL, QUEBEC–(Marketwired – March 7, 2018) - Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the “Company” or “Relevium”), is [...]
VistaGen Therapeutics Receives Notice of Allowance for a Key U.S. Patent Covering Treatment of Depression with AV-101
SAN FRANCISCO, CA–(Marketwired – March 07, 2018) – VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for [...]
Imagin Medical Product Re-Design on Schedule
VANCOUVER, BC and BOSTON, MA–(Marketwired – March 07, 2018) – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the “Company”), announced [...]
Pieris Pharmaceuticals to Present at Investor Conferences in March
BOSTON, MA–(Marketwired – March 06, 2018) – Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its [...]
Moleculin to Present at the 30th Annual ROTH Conference Tuesday, March 13, 2018
HOUSTON, TX–(Marketwired – March 06, 2018) – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical [...]
